Posiphen is under investigation in clinical trial NCT02925650 (Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.